Shandong Xinhua Pharmaceutical's Profit Down Slightly in H1

MT Newswires Live08-26

Shandong Xinhua Pharmaceutical (SHE:000756, HKG:0719) saw a 1.6% decline in attributable profit for the six months ended June 30 to 265.4 million yuan from 269.8 million yuan a year prior, an Aug. 22 bourse filing said.

Earnings per share stood at 0.38 yuan during the interim period, down from 0.39 yuan in the first half of 2023.

Operating revenue for the pharmaceutical firm rose by 1.3% to 4.73 billion yuan in H1 from 4.67 billion yuan during the corresponding period last year.

The company has recommended an interim dividend of 0.25 yuan per 10 shares for the half year.

Hong Kong-listed shares of the company closed over 1% higher on Monday.

Price (HKD): $5.34, Change: $+0.060, Percent Change: +1.14%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2462962170?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-26 18:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2462962170","market":"hk","top_or_hot":-1,"title":"Shandong Xinhua Pharmaceutical's Profit Down Slightly in H1","media":"MT Newswires Live","content":"<html><body><p> Shandong Xinhua Pharmaceutical (SHE:000756, HKG:0719) saw a 1.6% decline in attributable profit for the six months ended June 30 to 265.4 million yuan from 269.8 million yuan a year prior, an Aug. 22 bourse filing said.</p><p>Earnings per share stood at 0.38 yuan during the interim period, down from 0.39 yuan in the first half of 2023.</p><p>Operating revenue for the pharmaceutical firm rose by 1.3% to 4.73 billion yuan in H1 from 4.67 billion yuan during the corresponding period last year.</p><p>The company has recommended an interim dividend of 0.25 yuan per 10 shares for the half year.</p><p>Hong Kong-listed shares of the company closed over 1% higher on Monday.</p><p>Price (HKD): $5.34, Change: $+0.060, Percent Change: +1.14%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shandong Xinhua Pharmaceutical's Profit Down Slightly in H1</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShandong Xinhua Pharmaceutical's Profit Down Slightly in H1\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-26 18:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shandong Xinhua Pharmaceutical (SHE:000756, HKG:0719) saw a 1.6% decline in attributable profit for the six months ended June 30 to 265.4 million yuan from 269.8 million yuan a year prior, an Aug. 22 ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HKD","symbol_name":"尚乘数科","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2462962170","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2462962170","pubTimestamp":1724667376,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shandong Xinhua Pharmaceutical  saw a 1.6% decline in attributable profit for the six months ended June 30 to 265.4 million yuan from 269.8 million yuan a year prior, an Aug. 22 bourse filing said.Earnings per share stood at 0.38 yuan during the interim period, down from 0.39 yuan in the first half of 2023.Operating revenue for the pharmaceutical firm rose by 1.3% to 4.73 billion yuan in H1 from 4.67 billion yuan during the corresponding period last year.The company has recommended an interim dividend of 0.25 yuan per 10 shares for the half year.Hong Kong-listed shares of the company closed over 1% higher on Monday.Price : $5.34, Change: $+0.060, Percent Change: +1.14%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HKD":"尚乘数科","BK1191":"制药","BK4585":"ETF&股票定投概念","BK1515":"抗疫概念","BK0164":"国企混改","BK4588":"碎股","BK4526":"热门中概股","BK4023":"应用软件","000756":"新华制药","00719":"山东新华制药股份","BK0239":"医药制造"},"translate_title":"山东新华制药上半年利润略有下降","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HKD":1,"000756":0.9,"00719":0.9},"content_text":"Shandong Xinhua Pharmaceutical (SHE:000756, HKG:0719) saw a 1.6% decline in attributable profit for the six months ended June 30 to 265.4 million yuan from 269.8 million yuan a year prior, an Aug. 22 bourse filing said.Earnings per share stood at 0.38 yuan during the interim period, down from 0.39 yuan in the first half of 2023.Operating revenue for the pharmaceutical firm rose by 1.3% to 4.73 billion yuan in H1 from 4.67 billion yuan during the corresponding period last year.The company has recommended an interim dividend of 0.25 yuan per 10 shares for the half year.Hong Kong-listed shares of the company closed over 1% higher on Monday.Price (HKD): $5.34, Change: $+0.060, Percent Change: +1.14%","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2462962170"}